MoneyWorks4Me

The sales is pegged at Rs. 3484.89 millions for the December 2022 quarter. The mentioned figure indicates decline with the sales recorded at Rs. 3915.85 millions during the year-ago period.Net profit declined -20.09% to Rs. 1094.66 millions from Rs. 1369.94 millions.Operating Profit reported a sharp decline to 1595.77 millions from 1953.02 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 3484.89 3915.85 -11.01 9656.90 9563.74 0.97 13202.22 10097.19 30.75
Other Income 125.10 92.74 34.89 337.97 533.92 -36.70 1877.88 142.37 1219.01
PBIDT 1595.77 1953.02 -18.29 4422.46 4758.11 -7.05 7677.76 4547.59 68.83
Interest 13.79 7.42 85.85 31.02 40.43 -23.27 62.31 91.44 -31.86
PBDT 1581.98 1945.60 -18.69 4391.44 4717.68 -6.92 7615.45 4456.15 70.90
Depreciation 109.14 105.06 3.88 322.18 286.76 12.35 390.97 316.36 23.58
PBT 1472.84 1840.54 -19.98 4069.26 4430.92 -8.16 7224.48 4139.79 74.51
TAX 378.18 470.60 -19.64 1044.87 1094.59 -4.54 1643.49 1053.32 56.03
Deferred Tax 6.66 8.53 -21.92 28.29 33.09 -14.51 67.19 36.17 85.76
PAT 1094.66 1369.94 -20.09 3024.39 3336.33 -9.35 5580.99 3086.47 80.82
Equity 254.57 254.57 0.00 254.57 254.57 0.00 254.57 254.57 0.00
PBIDTM(%) 45.79 49.87 -8.19 45.80 49.75 -7.95 58.16 45.04 29.12

Cohance Lifesciences Share Price

456.55 -3.60 (-0.78%)
04-Sep-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1899.00
Dr. Reddys Labs. 1154.00
Cipla 1385.00
Lupin 2111.00
Zydus Lifesciences 1121.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: